ImmuPharma plc (LON:IMM – Get Free Report)’s share price rose 79.2% during trading on Thursday . The company traded as high as GBX 2.49 ($0.03) and last traded at GBX 2.15 ($0.03). Approximately 21,651,871 shares traded hands during mid-day trading, an increase of 379% from the average daily volume of 4,518,033 shares. The stock had previously closed at GBX 1.20 ($0.01).
ImmuPharma Trading Up 4.9 %
The firm has a market capitalization of £15.30 million, a price-to-earnings ratio of -367.30 and a beta of 1.53. The firm has a 50 day moving average price of GBX 1.40 and a two-hundred day moving average price of GBX 1.65.
ImmuPharma Company Profile
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
Further Reading
- Five stocks we like better than ImmuPharma
- What Is WallStreetBets and What Stocks Are They Targeting?
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Investing in Construction Stocks
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- 3 REITs to Buy and Hold for the Long Term
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
